This New Drug Could Solve the GLP-1 Plateau Problem

Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.

BY SAGE SWABY, EDITORIAL FELLOW @SAGESWABY

An experimental drug is making waves as it has shown to reduce both blood glucose and weight. Healthcare company Roche Pharmaceuticals saw positive results from a clinical trial that evaluated experimental drug enicepatide in 447 adults living with type 2 diabetes (T2D) and obesity. 

Patients were administered enicepatide once weekly........

© Inc.com